Category

PR

Notice of The Twentieth Annual General Meeting of Shareholders

By | EN, PR

TAIPEI, Taiwan, May 25, 2019 /PRNewswire/ —

GigaMedia Limited
Incorporated in the Republic of Singapore
Registration No.: 199905474H

REGISTERED OFFICE
80 Robinson Road, #02-00
Singapore 068898

NOTICE IS HEREBY GIVEN that the 20th annual general meeting of the shareholders of GigaMedia Limited (the "Company") will be held on June 28, 2019 at 11 a.m. local time at Flat C, 7/F, Lucky Horse Industrial Building, 64 Tong Mi Road, Mongkok, Kowloon, Hong Kong, for the following purposes:

AS ORDINARY AND SPECIAL BUSINESS

ORDINARY RESOLUTIONS:

To consider and, if thought fit, to pass, with or without modification, the following resolutions which will be proposed as Ordinary Resolutions:

1.     Adoption of audited financial statements

          RESOLVED that the Statement by the Directors, Auditor’s Report and Audited Financial Statements of the Company for the financial year ended December 31, 2018 are received and adopted.
(Resolution 1)

2.     Approval of appointment of auditors

          RESOLVED that Deloitte & Touche and Deloitte & Touche LLP be and are hereby appointed as the independent external auditors of the Company until the next Annual General Meeting and that the Directors be and are hereby authorized to fix their remuneration.
(Resolution 2)

3.     Approval of Directors’ remuneration

          RESOLVED that the remuneration of the Directors is hereby approved in an aggregate amount not exceeding US$350,000 in respect of their professional services to the Company until the conclusion of the next Annual General Meeting of the Company.
(Resolution 3)

4.     Approval for authority to allot and issue shares

          RESOLVED that pursuant to Section 161 of the Companies Act, Chapter 50 of Singapore ("Companies Act"), authority be and is hereby given to the Directors of the Company to:

(1)           (a)           issue ordinary shares in the Company ("Shares") whether by way of rights, bonus or otherwise; and/or

               (b)           make or grant offers, agreements or options (collectively, "Instruments") that might or would require Shares to be issued, including but not limited to the creation and issue of (as well as adjustments to) options, warrants, debentures or other instruments convertible into Shares,

               at any time and upon such terms and conditions and for such purposes and to such persons as the Directors may in their absolute discretion deem fit; and

(2)           notwithstanding that the authority conferred by this Resolution may have ceased to be in force, issue Shares pursuant to any Instrument made or granted by the Directors while this Resolution was in force; and

(3)           unless varied or revoked by the Company in general meeting, such authority conferred on the Directors of the Company shall continue in force:

               (i)             until the conclusion of the next Annual General Meeting of the Company or the date by which the next Annual General Meeting of the Company is required by law to be held whichever is earlier; or

               (ii)            in the case of Shares to be issued in pursuance of the Instruments, made or granted pursuant to this Resolution, until the issuance of such Shares in accordance with the terms of the Instruments.

(Resolution 4)

5.     Approval for share purchase mandate      

          RESOLVED that:

(1)           for the purposes of Sections 76C and 76E of the Companies Act, the exercise by the Directors of the Company of all the powers of the Company to purchase or otherwise acquire issued Shares not exceeding in aggregate the Maximum Limit (as hereafter defined), at such price or prices as may be determined by the Directors from time to time up to the Maximum Price (as hereafter defined), by way of market purchase(s) on The Nasdaq Stock Market ("Nasdaq") or off-market purchase(s) on an equal access scheme(s) as may be determined by the Directors as they see fit, which scheme(s) shall satisfy all the conditions of the Companies Act, and otherwise in accordance with all other laws and regulations and rules of Nasdaq as may for the time being be applicable, be and is hereby authorized and approved generally and unconditionally (the "Share Purchase Mandate");

(2)           unless varied or revoked by the Company in a general meeting, the authority conferred on the Directors of the Company pursuant to the Share Purchase Mandate may be exercised by the Directors at any time and from time to time during the period commencing from the date of the passing of this Resolution and expiring on the earlier of:

               (a)           the date on which the next Annual General Meeting of the Company is held; and

               (b)           the date by which the next Annual General Meeting of the Company is required by law to be held;

(3)           in this Resolution:

          "Average Closing Price" means the average of the last dealt prices of a Share for the five consecutive trading days on which the Shares are transacted on Nasdaq immediately preceding the date of market purchase by the Company or the date of making the offer pursuant to an equal access scheme and deemed to be adjusted in accordance with the listing rules of Nasdaq for any corporate action which occurs after the relevant five day period;

          "Maximum Limit" means that number of issued Shares representing 10% of the total number of issued Shares as at the date of the passing of this Resolution (excluding any Shares which are held as treasury shares as at that date); and

          "Maximum Price", in relation to a Share to be purchased or acquired pursuant to the Share Purchase Mandate, means the purchase price (excluding brokerage, commission, applicable goods and services tax and other related expenses) which shall not exceed 105% of the Average Closing Price of the Shares; and

(4)            the Directors of the Company and/or any of them be and are hereby authorized to complete and do all such acts and things (including executing such documents as may be required) as they and/or he may consider expedient or necessary to give effect to the transactions contemplated and/or authorized by this Resolution.

(Resolution 5)

6.     To transact any other business as may properly be transacted at an Annual General Meeting of the Company.

NOTES:

1.     Shareholders are cordially invited to attend the Twentieth Annual General Meeting in person.  Whether or not you plan to be at the Twentieth Annual General Meeting, you are urged to return your proxy.  A shareholder entitled to attend and vote is entitled to appoint one or more proxies to attend and to vote instead of him.

2.     Shareholders wishing to vote by proxy should complete the attached form.

3.     The proxy form of an individual shareholder shall be signed either by the shareholder personally or by his attorney. The proxy form of a corporate shareholder shall be given either under its common seal or signed on its behalf by an attorney or a duly authorized officer of the corporate shareholder.

4.     A proxy need not be a shareholder of the Company.

5.     The proxy form (and if relevant, the original power of attorney, or other authority under which it is signed or a notarially certified copy of such power or authority) must be deposited at Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717, or the office of the Company, 8F, No. 22, Lane 407, Section 2, Tiding Boulevard, Taipei 114, Taiwan R.O.C., not less than 48 hours before the time for holding the Twentieth Annual General Meeting, that is by no later than 11 p.m. June 25, 2019 (New York time), or 11 a.m. June 26, 2019 (Taipei time), failing which the proxy shall not be treated as valid.

6.     Electronic Delivery of Future Proxy Materials.  Shareholders can consent to receiving all future proxy statements, proxy card and annual reports electronically via e-mail or the internet. To sign up for electronic delivery, please follow the instructions below relating to "Electronic Delivery of Future Proxy Materials" and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years.

7.       Only shareholders of record at the close of business on April 26, 2019 are entitled to notice of and to vote at the Twentieth Annual General Meeting, or any adjournment or postponement of the Twentieth Annual General Meeting.

8.     The Company intends to use internal sources of funds or external borrowings or a combination of both to finance the Company’s purchase or acquisition of the Shares pursuant to the Share Purchase Mandate.  The Directors do not propose to exercise the Share Purchase Mandate to such extent that it would materially and adversely affect the financial position of the Company and its subsidiaries.  The amount of financing required for the Company to purchase or acquire its Shares, and the impact on the Company’s financial position, cannot be ascertained as at the date of this Notice as this will depend on the number of Shares purchased or acquired, the price at which such Shares were purchased or acquired and whether the Shares purchased or acquired would be held in treasury or cancelled.

 

BY ORDER OF THE BOARD

 

/s/ Cheng-Ming Huang
………………………………………..
Cheng-Ming Huang (aka James Huang)
Chairman of the Board and Chief Executive Officer

 

TABLE OF CONTENTS

NOTICE OF ANNUAL MEETING OF SHAREHOLDERS

PROXY STATEMENT

                Questions and Answers about the Annual Meeting and Voting
                Proposal 1
                Proposal 2
                Proposal 3
                Proposal 4
                Proposal 5           

                Other Matters
                Proxy Solicitation

 

 

 

GigaMedia Limited
Incorporated in the Republic of Singapore
Registration No.: 199905474H

REGISTERED OFFICE
80 Robinson Road, #02-00
Singapore 068898

—————————————————–
PROXY STATEMENT
—————————————————–

QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING AND VOTING

Why Did I Receive This Proxy Statement?

          We sent you this proxy statement and the enclosed proxy card because the Company’s Board of Directors is soliciting your proxy to be used at the Company’s annual meeting of shareholders on June 28, 2019 at Flat C, 7/F, Lucky Horse Industrial Building, 64 Tong Mi Road, Mongkok, Kowloon, Hong Kong, or at any adjournment or postponement of the meeting. 

Who Can Vote?

          You are entitled to vote if you owned the Shares on the record date ("Record Date"), which is the close of business on April 26, 2019.  Each Share that you own entitles you to one vote.

How Many Shares of Voting Stock Are Outstanding?

          On the Record Date, there were 11,052,235 Shares outstanding.  The Shares are our only class of voting stock.

What May I Vote On?

1. Adoption of Audited Financial Statements
2. Approval of Appointment of Auditors
3. Approval of Directors’ Remuneration
4. Approval for Authority to Allot and Issue Shares
5. Approval for Share Purchase Mandate

Other Business

How Do I Vote?

          To vote by proxy, you should complete, sign and date the enclosed proxy card and return it promptly in the prepaid envelope provided.

Electronic Delivery of Future Proxy Materials

          If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the internet. To sign up for electronic delivery, please go to www.proxyvote.com to indicate that you agree to receive or access proxy materials electronically in future years.

May I Revoke My Proxy?

          Your proxy may be revoked prior to its exercise by appropriate notice to the undersigned.

If I Plan To Attend The Meeting, Should I Still Vote By Proxy?

          Whether you plan to attend the meeting or not, we urge you to vote by proxy.  Returning the proxy card will not affect your right to attend the meeting, and your proxy will not be used if you are personally present at the meeting and inform the Secretary in writing prior to the voting that you wish to vote your Shares in person.

How Will My Proxy Get Voted?

          If you properly fill in your proxy card and send it to us, your proxy holder (the individual named on your proxy card) will vote your Shares as you have directed.  If you sign the proxy card but do not make specific choices, the proxy holder will vote your Shares as recommended by the Board of Directors and the Company’s management.

How Will Voting On Any Other Business Be Conducted?

          Although we do not know of any business to be considered at the meeting other than the proposals described in this proxy statement, if any other business is presented at the meeting, your returned proxy gives authority to the proxy holder to vote on these matters in his discretion.

Proposal 1.            ADOPTION OF AUDITED FINANCIAL STATEMENTS

          The Company seeks shareholders’ adoption of the audited financial statements of the Company (the "Audited Financial Statements"), which have been prepared under Financial Reporting Standards in Singapore ("FRSs") , in respect of the financial year ended December 31, 2018. Along with the Audited Financial Statements, the Company seeks Shareholders’ adoption of the  Statement by the Directors and Auditor’s Report of the Company in respect of the same financial year.

          Adoption of this proposal requires the affirmative vote of a majority of the votes cast by shareholders entitled to vote at the Twentieth Annual General Meeting of the Company ("AGM").

          The Board of Directors of the Company (the "Board of Directors") recommends a vote FOR this proposal.

Proposal 2.            APPROVAL OF APPOINTMENT OF AUDITORS

          The Company seeks Shareholders’ approval for the appointment of Deloitte & Touche and Deloitte & Touche LLP as the independent external auditors of the Company to hold such office until the conclusion of the next Annual General Meeting of the Company. The Board of Directors also seeks shareholders’ approval to authorize the Board of Directors to fix the remuneration for Deloitte & Touche and Deloitte & Touche LLP in respect of their service to the Company for the financial year ended December 31, 2019.

          Adoption of this proposal requires the affirmative vote of a majority of the votes cast by shareholders entitled to vote at the AGM.

          The Board of Directors recommends a vote FOR this proposal.

Proposal 3.            APPROVAL OF DIRECTORS’ REMUNERATION

          The Company seeks shareholders’ approval on the remuneration of Directors in an aggregated amount not exceeding US$350,000 in respect of their professional services to the Company until the conclusion of the next Annual General Meeting of the Company.

          Adoption of this proposal requires the affirmative vote of a majority of the votes cast by shareholders entitled to vote at the AGM.

          The Company’s management recommends a vote FOR this proposal.

Proposal 4.            APPROVAL FOR AUTHORITY TO ALLOT AND ISSUE SHARES

          The Company is incorporated in Singapore. Under the Companies Act, Chapter 50 of Singapore (the "Companies Act"), the Directors may exercise any power of the Company to issue new Shares only with the prior approval of the shareholders of the Company at a general meeting. Such approval, if granted, is effective from the date of the general meeting at which the approval was given until the date on which the next Annual General Meeting of the Company is held or is required by law to be held, whichever is earlier.

          Shareholders’ approval is sought to give Directors authority to allot and issue new Shares and other instruments convertible into Shares during the period from the Twentieth Annual General Meeting to the earlier of the next Annual General Meeting or the date by which the next Annual General Meeting of the Company is required by law to be held.

          Adoption of this proposal requires the affirmative vote of a majority of the votes cast by shareholders entitled to vote at the AGM.

          The Board of Directors recommends a vote FOR this proposal.

Proposal 5.            APPROVAL FOR SHARE PURCHASE MANDATE

          The approval of the Share Purchase Mandate authorizing the Company to purchase or acquire its Shares would give the Company the flexibility to undertake share purchases or acquisitions at any time, subject to market conditions, during the period when the Share Purchase Mandate is in force.

          In managing the business of the Company and its subsidiaries (the "Group"), the Company’s management strives to increase shareholders’ value by improving, inter alia, the return on equity of the Group. A share purchase by the Company is one of the ways through which the return on equity of the Group may be enhanced.

          A Share purchase is also an available option for the Company to return surplus cash which is in excess of the financial and possible investment needs of the Group to its shareholders. In addition, the Share Purchase Mandate will allow the Company to have greater flexibility over, inter alia, the Company’s share capital structure and its dividend policy. 

          The Company intends to use internal sources of funds or external borrowings or a combination of both to finance the Company’s purchase or acquisition of the Shares pursuant to the Share Purchase Mandate.  The Directors do not propose to exercise the Share Purchase Mandate to such extent that it would materially and adversely affect the financial position of the Group.

          Share repurchase programmes may also help buffer short-term share price volatility and off-set the effects of short-term speculators and investors and, in turn, bolster shareholder confidence and employee morale.

          Adoption of this proposal requires the affirmative vote of a majority of the votes cast by shareholders entitled to vote at the AGM.

          The Board of Directors recommends a vote FOR this proposal.

OTHER MATTERS

          As of the date of this Proxy Statement, the Company does not intend to present and has not been informed that any other person intends to present any business not specified in this Proxy Statement for action at the Twentieth Annual General Meeting.

          Shareholders are urged to sign the enclosed proxy form and to return it promptly in the enclosed envelope. Proxies will be voted in accordance with shareholders’ directions. Signing the proxy form does not affect a shareholder’s right to vote at the Twentieth Annual General Meeting, and the proxy may be revoked prior to its exercise by appropriate notice to the undersigned.

PROXY SOLICITATION

          The Company will pay the cost of preparing and mailing this proxy statement and form of proxy to its shareholders. The Company has retained Mackenzie Partners, Inc. to request banks and brokers to forward copies of these materials to persons for whom they hold Shares and to request authority for execution of the proxies.

 

GIGAMEDIA LIMITED

/s/ Cheng-Ming Huang
………………………………………..
Cheng-Ming Huang (aka James Huang)
Chairman of the Board and Chief Executive Officer

 

Cision View original content:http://www.prnewswire.com/news-releases/notice-of-the-twentieth-annual-general-meeting-of-shareholders-300856867.html

Related Links :

http://www.gigamedia.com

Are you a Corporate Representative of GigaMedia Limited, an investor, or a member of the Business Press?



Natura &Co dan Avon ganding bahu wujudkan peneraju kecantikan global Terus-kepada-Pengguna

By | MY, PR

SÃO PAULO dan LONDON, 25 Mei 2019 /PRNewswire/ — Natura &Co (B3: NATU3) mengumumkan bahawa ia mengambil alih Avon Products, Inc. (NYSE: AVP) dalam urus niaga semua-saham, mewujudkan kumpulan bidang khusus kecantikan yang keempat terbesar di dunia dan pendorong utama kebaikan dalam industri.

Kombinasi ini mewujudkan kumpulan kecantikan berbilang jenama dan berbilang saluran yang terbaik dalam kelasnya, dengan hubungan langsung bersama pengguna setiap hari. Kumpulan ini akan memainkan peranan utama dalam hubungan jualan melalui lebih 6.3 juta Perunding dan Wakil Avon dan Natura, jejak global melalui 3,200 kedai selain kehadiran digital yang diperluas dalam semua syarikat. Gabungan Kumpulan ini dijangka mencatatkan pendapatan kasar tahunan sebanyak lebih US$10 bilion, lebih 40,000 rakan gabungan dan berada di 100 negara.

Memanfaatkan jenama-jenama ikoniknya, minat yang sama terhadap hubungan dan keupayaan omnisalurannya, kumpulan yang diperluas itu akan membawakan kecantikan kepada lebih 200 juta pengguna di seluruh dunia, pada bila-bila masa, di mana-mana juga, setiap hari. Dengan menambah Avon ke dalam portfolio yang telahpun melibatkan Natura, The Body Shop dan Aesop, Natura &Co akan meningkatkan kebolehannya unutk menawarkan perkhidmatan yang lebih baik kepada profil pengguna berbeza dan saluran pengedaran dan berkembang ke kawasan-kawasan baharu.

Avon dan Natura kedua-duanya ditubuhkan oleh individu-individu yang didorong misi, mendekati pelanggan melalui kuasa bebas, khususnya mikrousahawan wanita yang bertindak sebagai duta jenama dan penasihat kecantikan. Avon ialah satu jenama ikonik dengan warisan selama lebih 130 tahun dan merupakan platform kecantikan hubungan jualan yang terkemuka di dunia. Jenama-jenama kukuhnya dalam kategori-kategori kecantikan utama serta kedudukan kompetitif dalam beberapa pasaran memberikannya potensi penting untuk pertumbuhan masa depan.

Natura &Co menjangkakan kombinasi ini akan menghasilkan sinergi sasaran dengan anggaran US$150 juta hingga US$250 juta setahun, sebahagiannya akan dilaburkan semula untuk terus meningkatkan keupayaan dalam jualan digital dan sosial, penyelidikan & pembangunan serta inisiatif jenama dan untuk terus mengembangkan jejak geografi Kumpulan.

Luiz Seabra, Pengasas Bersama Natura, menyatakan: "Kami sentiasa melihat Avon dengan rasa hormat dan kagum. Natura ditubuhkan berdasarkan minatnya terhadap kecantikan dan hubungan serta urus niaga masa kini mewujudkan kuasa utama dalam bidang terus-kepada-pengguna. Jualan langsung ialah satu jaringan sosial sebelum perkataan tersebut wujud dan kemunculan teknologi dan globalisasi hanya menggandakan peluang untuk berhubung bersama pengguna dengan cara yang bermakna. Model jualan rakan-kepada-rakan berkembang ke arah jualan sosial dan kuasa digital membolehkan kumpulan ini melakukan lebih daripada sekadar menyediakan produk dan khidmat nasihat serta memajukan pemberdayaan wanita, melalui kebebasan kewangan dan harga diri yang dipertingkat. Kami percaya bahawa perniagaan dapat menjadi kuasa kebaikan dan bersama-sama Avon, kami akan menggiatkan usaha-usaha rintis kami untuk membawa nilai sosial, alam sekitar dan ekonomi kepada rangkaian yang sentiasa berkembang."

Roberto Marques, Pengerusi Eksekutif Natura &Co, menyatakan: "Susulan pengambilalihan Aesop pada tahun 2013 dan The Body Shop pada tahun 2017, Natura & Co mengambil satu lagi langkah menarik yang muktamad untuk membina Kumpulan dipacu tujuan yang bertaraf global, berbilang jenama dan berbilang saluran. Avon ialah sebuah syarikat yang hebat, jenama yang ikonik, bersama rakan-rakan gabungan yang bersemangat serta lebih lima juta Wakil yang juga percaya dengan kuasa hubungan. Kami akan bersama-sama meningkatkan keupayaan digital kami yang semakin berkembang, rangkaian sosial Perunding dan Wakil kami serta memanfaatkan jejak kedai global kami dan juga jenama-jenama tersendiri, berhubung, menyentuh dan mempengaruhi berjuta-juta pengguna dengan profil-profil berbeza setiap hari, lalu menjadikan Kumpulan kami unik dan mewujudkan platform yang mengagumkan untuk pertumbuhan."

Jan Zijderveld, Ketua Pegawai Eksekutif Avon, berkata: "Kombinasi ini merupakan permulaan kepada lembaran baharu yang mengujakan dalam sejarah 130 tahun Avon. Ia menjadi bukti kemajuan usaha-usaha kami untuk ‘Membuka Avon’ (‘Open Up Avon’) dan kami percaya bahawa ia akan membolehkan kami mempercepatkan strategi kami dengan signifikan dan terus berkembang ke dalam saluran dalam talian. Sepanjang tahun lalu, kami telah memulakan satu transformasi untuk mengukuhkan daya saing Avon dengan memperbaharui tumpuan kami terhadapnya, memudahkan operasi kami dan memodenkan serta mendigitalkan jenama kami. Bersama-sama Natura, kami akan mendapat akses yang lebih luas kepada inovasi dan portfolio produk, platform e-dagang dan digital yang lebih mantap serta data dan alatan yang lebih baik untuk Wakil-wakil memacu pertumbuhan dan meningkatkan nilai buat pemegang saham. Selanjutnya, dengan sokongan Natura, kami akan terus melabur dalam teknologi terkini bagi meningkatkan keupayaan digital kami dan produktiviti untuk Wakil-wakil kami. Avon dan Natura merupakan organisasi-organisasi didorong matlamat dan kombinasi berkenaan akan membolehkankami menawarkan perkhidmatan yang lebih baik kepada berjuta-juta Wakil kami, memanfaatkan kehadiran antarabangsa digital kami dengan komitmen sama yang dipegang kukuh untuk meningkatkan pengalaman dan pendapatannya."

Chan Galbato, Pengerusi Bukan Eksekutif Avon berkata: "Tumpuan kami adalah untuk meningkatkan pengalaman Wakil-wakil, mempercepatkan peluasan antarabangsa, menambah baik struktur kos kami, meningkatkan kefleksibelan kewangan dan akhirnya meletakkan syarikat di kedudukan untuk mencapai pertumbuhan dan kejayaan jangka panjang. Pihak Lembaga komited untuk meningkatkan nilai buat pemegang saham dan kombinasi dengan Natura ini membawakan era baharu pertumbuhan masa depan untuk Avon. Lembaga Avon yakin bahawa Natura akan menjadi rakan kongsi yang hebat untuk jenama Avon, di samping menyediakan lebih skala, operasi dan peluang yang diperluas untuk kakitangan dan Wakil-wakil serta potensi peningkatan nilai yang sangat besar untuk kedua-dua kumpulan pemegang saham. Kami berasa gembira untuk menyokong kombinasi transformasi ini."

Sebagai sebahagian daripada urus niaga ini, syarikat induk Brazil baharu, Natura Holding S.A., telahpun ditubuhkan. Berdasarkan nisbah tukaran tetap saham 0.300 Natura Holding untuk setiap saham bagi stok biasa Avon, pemegang saham Natura &Co akan memiliki kira-kira 76% daripada gabungan syarikat berkenaan, manakala pemegang saham biasa Avon akan memiliki kira-kira 24%. Berdasarkan harga penutupan tak terganggu Natura pada 21 Mac 2019, sehari sebelum Natura mengeluarkan Fakta Material yang mengesahkan rundingan antara Avon dan Natura, urus niaga tersebut mewakili 28% premium untuk pemegang saham Avon dan membayangkan EBITDA 2018 berganda 9.5x atau 5.6x yang mengandaikan impak penuh sinergi-sinergi Natura yang dijangkakan. Berdasarkan harga penutupan pada 21 Mei 2019, urus niaga tersebut memberi nilai kepada Avon pada nilai perusahaan sebanyak US$3.7 bilion dan gabungan kumpulan tersebut akan mendapat nilai perusahaan kira-kira US$11 bilion. Selepas ditutup, stok Natura Holding S.A.akan disenaraikan pada B3 dengan 55% apungan awam dan ia juga akan mempunyai ADR yang disenaraikan pada NYSE. Pemegang saham Avon akan mempunyai pilihan untuk menerima ADR yang diniagakan di NYSE atau saham yang disenaraikan pada B3. Maklumat lanjut disediakan dalam Fakta Material yang boleh diakses melalui pautan berikut https://natu.infoinvest.com.br/ptb/7085/19550_691987.pdf

Selepas ditutup, Lembaga Pengarah gabungan syarikat berkenaan akan terdiri daripada 13 ahli, 3 daripadanya akan ditentukan oleh Avon. Urus niaga berkenaan masih tertakluk kepada syarat-syarat penutupan biasa termasuk kelulusan oleh kedua-dua pemegang saham Natura &Co dan Avon serta pihak berkuasa antitrust di Brazil dan bidang-bidang kuasa tertentu yang lain. Penutupan dijangkakan pada awal tahun 2020.

UBS Investment Bank dan Morgan Stanley bertindak sebagai penasihat kewangan Natura &Co. Goldman Sachs bertindak sebagai penasihat kewangan Avon manakala PJT Partners bertindak sebagai penasihat kewangan kepada ahli-ahli dalam Lembaga Pengarah Avon.

Panggilan Persidangan dan Siar Web

NATURA &Co akan mengadakan panggilan persidangan dan siar web pada hari Khamis, 23 Mei pada jam 9:00 PAGI BRT, 8:00 PAGI EST untuk membincangkan tentang urus niaga berkenaan.

Panggilan persidangan tersebut boleh diakses dengan mendail +55 11 3193-1001 atau +55 11 2820-4001 untuk Brazil, +1-646-828-8246 atau Talian Bebas Tol: 1-800-492-3904 untuk AS dan Kanada serta +44 20 7442-5660 atau Talian Bebas Tol 0-808-111-0152 untuk United Kingdom. Kod pengesahan ialah Natura. Peserta-peserta perlu mendail 10 minit sebelum waktu bermula yang dijadualkan.

Siar web secara langsung panggilan persidangan tersebut dan bahan-bahan pembentangan berkaitan akan disediakan dalam bahagian perhubungan pelabur di laman sesawang setiap syarikat di http://choruscall.com.br/natura/extramay.htm 

Latar Belakang NATURA &CO

Hasil daripada gabungan antara Natura, Aesop dan The Body Shop, jenama korporat Natura &Co menyatukan penciptaan kumpulan kosmetik bertaraf global, berbilang saluran dan berbilang jenama yang didorong matlamat. Ketiga-tiga syarikat tersebut yang membentuk kumpulan berkenaan komited untuk menghasilkan kesan ekonomi, sosial dan alam sekitar yang positif. Ditubuhkan pada tahun 1969, Natura ialah sebuah syarikat multinasional Brazil dalam segmen kosmetik dan penjagaan peribadi, peneraju bagi jualan langsung. Ditubuhkan pada tahun 1976 di Brighton, England, oleh Anita Roddick, The Body Shop ialah jenama kecantikan global yang berusaha untuk mencetuskan perbezaan positif di dunia. Jenama kecantikan Australia Aesop ditubuhkan pada tahun 1987 dengan usaha untuk mencipta rangkaian produk superlatif untuk kulit, rambut dan tubuh.

Latar Belakang Avon Products, Inc.

Selama 130 tahun Avon telah berjuang untuk wanita: menyediakan produk-produk kecantikan yang inovatif dan berkualiti yang dijual khususnya untuk wanita, melalui wanita. Berjuta-juta Wakil bebas di seluruh dunia menjual jenama-jenama Avon yang ikonik seperti Avon Color dan ANEW melalui rangkaian sosial mereka, membina perniagaan kecantikan mereka sendiri secara sepenuh masa atau sambilan. Avon menyokong pemberdayaan, keusahawanan serta kesejahteraan wanita dan telah menyumbang lebih $1 bilion kepada gerakan wanita melalui Avon dan Avon Foundation. Ketahui lebih lanjut tentang Avon dan produk-produknya di www.avonworldwide.com. #Stand4Her.

Pertanyaan media Natura &Co:
Marcelo Behar, Pegawai Hal Ehwal Korporat Natura &Co
[email protected]

Perhubungan Pelabur Natura &Co:
Viviane Behar de Castro, Pengarah Perhubungan Pelabur, Natura &Co
[email protected]

Pertanyaan media Avon:
Natalie Deacon, Pengarah Eksekutif Komunikasi, Avon Products, Inc.
+ 44(0) 7725 150853
Emel: [email protected]  / [email protected]

Perhubungan Pelabur Avon:
Amy Greene, Naib Presiden, Perhubungan Pelabur, Avon Products, Inc.
+ 001 212 282 5320
Emel: [email protected]

TIADA TAWARAN ATAU PERMOHONAN

Komunikasi ini adalah untuk tujuan maklumat sahaja dan bukan merupakan tawaran untuk menjual atau permohonan tawaran untuk membeli mana-mana sekuriti atau permohonan apa-apa undian atau kelulusan, dan tidak ada apa-apa jualan sekuriti di mana-mana bidang kuasa yang mana tawaran, permohonan atau jualan berkenaan akan menyalahi undang-undang sebelum pendaftaran atau kelayakan di bawah undang-undang sekuriti bidang kuasa berkenaan.

MAKLUMAT TAMBAHAN DAN DI MANA UNTUK MENDAPATKANNYA

Komunikasi ini dibuat berkenaan dengan cadangan urus niaga yang melibatkan Natura Holding S.A. (secara kolektif dengan Natura Cosmeticos S.A., "Natura") dan Avon Products, Inc. ("Avon"). Berkaitan dengan the urus niaga yang dicadangkan, Natura akan memfailkan kenyataan pendaftaran dengan Suruhanjaya Sekuriti dan Bursa ("SEC") dalam Borang F-4 yang akan menyertakan kenyataan proksi Avon dan prospektus Natura. Natura dan Avon juga merancang untuk memfailkan dokumen-dokumen lain dengan SEC berhubung urus niaga yang dicadangkan dan kenyataan proksi/prospektus bersama akan dihantar kepada pemegang saham Avon. Komunikasi ini bukan pengganti kepada mana-mana kenyataan proksi, kenyataan pendaftaran, kenyataan proksi/prospektus atau dokumen-dokumen lain yang mungkin difailkan oleh Natura dan/atau Avon dengan SEC berhubung dengan urus niaga yang dicadangkan. SEBELUM MEMBUAT APA-APA KEPUTUSAN UNDIAN ATAU PELABURAN, PELABUR DIGESA UNTUK MEMBACA BORANG F-4 DAN KENYATAAN PROKSI/PROSPEKTUF BERSAMA BERHUBUNG URUS NIAGA YANG DICADANGKAN DAN APA-APA DOKUMEN LAIN YANG BERKAITAN DENGAN TELITI SECARA SEPENUHNYA APABILA IA TERSEDIA KERANA IA AKAN MENGANDUNGI MAKLUMAT PENTING TENTANG URUS NIAGA YANG DICADANGKAN. Borang F-4 dan kenyataan proksi/prospektus bersama serta pemfailan lain yang mengandungi maklumat tentang Natura dan Avon, akan disediakan secara percuma di laman Internet SEC (www.sec.gov). Salinan kenyataan proksi/prospektus bersama juga boleh diperoleh, apabila tersedia, secara percuma daripada laman sesawang Natura di www.NaturaeCo.com. Salinan kenyataan proksi/prospektus bersama juga boleh diperoleh, apabila tersedia, secara percuma daripada laman sesawang Avon di www.AvonWorldwide.com.

PESERTA-PESERTA DALAM PERMOHONAN  

Natura dan Avon, pengarah, pegawai eksekutif dan ahli-ahli lain dalam bahagian pengurusan mereka serta kakitangan masing-masing, boleh dianggap sebagai peserta-peserta dalam permohonan proksi berhubung dengan urus niaga yang dicadangkan. Maklumat berhubung individu-individu yang mungkin, di bawah peraturan SEC, dianggap sebagai peserta-peserta dalam permohonan proksi berhubung dengan urus niaga yang dicadangkan, termasuk penerangan tentang kepentingan langsung atau tidak langsung, melalui pemegangan sekuriti atau sebaliknya, akan dinyatakan dalam kenyataan proksi/prospektus bersama serta bahan-bahan berkaitan lain apabila difailkan dengan SEC. Maklumat berhubung pengarah dan pegawai eksekutif Natura terkandung dalam Borang Rujukan Natura bagi tahun 2018, versi 15, yang difailkan dengan Suruhanjaya Sekuriti Brazil pada 24 April 2019. Maklumat berhubung pengarah dan pegawai eksekutif Avon terkandung dalam kenyataan proksi definitif Avon untuk mesyuarat tahunan pemegang saham tahun 2019, difailkan dengan SEC pada 2 April 2019. Dokumen-dokumen ini boleh didapati secara percuma daripada sumber-sumber yang dinyatakan di atas.

PERINGATAN TENTANG KENYATAAN PANDANG KE HADAPAN

Kenyataan-kenyataan dalam komunikasi ini (atau dalam dokumen yang dikemukakan oleh rujukan) yang bukan fakta atau maklumat bersejarah mungkin merupakan kenyataan pandang ke hadapan mengikut pengertian Akta Reformasi Litigasi Sekuriti Persendirian 1995. Antara perkara lain, kenyataan pandang ke hadapan ini mungkin termasuk kenyataan berhubung urus niaga yang dicadangkan melibatkan Natura dan Avon; kepercayaan berkaitan penciptaan nilai hasil daripada urus niaga yang dicadangkan melibatkan Natura dan Avon; jadual yang dijangkakan untuk menyelesaikan urus niaga tersebut; faedah dan sinergi urus niaga; peluang masa depan untuk gabungan syarikat; dan mana-mana kenyataan lain berhubung kepercayaan, jangkaan, rancangan, hasrat, keadaan kewangan atau prestasi masa depan Natura dan Avon. Dalam sesetengah keadaan, perkataan seperti "anggaran", "unjuran", "ramalan" , "merancang", "percaya", "mungkin", "berharap", "menjangkakan", "berhasrat", "dirancang", "berpotensi", "boleh", "jangkaan", "dapat", "bakal", "akan" dan ungkapan yang serupa, atau negatif daripada ungkapan tersebut, dapat mengenal pasti kenyataan pandang ke hadapan. Kenyataan pandang ke hadapan ini adalah berdasarkan jangkaan dan kepercayaan Avon dan Natura berhubung peristiwa masa depan dan melibatkan risiko serta ketidaktentuan yang mungkin menyebabkan keputusan sebenar berbeza dengan ketara daripada jangkaan semasa. Faktor-faktor ini sukar diramalkan dengan tepat dan mungkin di luar kawalan Natura dan Avon. Kenyataan pandang ke hadapan dalam komunikasi ini atau di tempat lain hanya tepat setakat tarikh ia dibuat. Ketidaktentuan dan risiko baharu muncul dari masa ke masa dan mustahil untuk Natura atau Avon meramalkan peristiwa ini atau bagaimana ia boleh menjejaskan Natura atau Avon. Oleh itu, anda tidak seharusnya bergantung pada mana-mana kenyataan pandang ke hadapan ini sebagai peramal peristiwa masa depan. Kecuali dikehendaki oleh undang-undang, Natura atau Avon tidak mempunyai kewajipan untuk, dan tidak berhasrat untuk, mengemas kini atau menyemak semula kenyataan pandang ke hadapan dalam komunikasi ini atau di tempat lain selepas tarikh komunikasi ini diterbitkan. Lantaran risiko dan ketidaktentuan ini, pelabur perlu ingat bahawa keputusan, peristiwa atau pembangunan yang dibincangkan dalam mana-mana kenyataan pandang ke hadapan yang dibuat dalam komunikasi ini mungkin tidak berlaku. Ketidaktentuan dan faktor risiko yang boleh menjejaskan prestasi masa depan Natura dan/atau Avon dan menyebabkan keputusan berbeza daripada kenyataan pandang ke hadapan dalam komunikasi ini termasuk, tetapi tidak terhad kepada, (a) kebolehan pihak-pihak untuk menyempurnakan urus niaga tersebut atau memenuhi syarat-syarat penyempurnaan urus niaga tersebut, termasuk penerimaan kelulusan pemegang saham dan penerimaan kelulusan kawal selia yang diperlukan untuk urus niaga tersebut menurut terma yang dijangkakan atau mengikut jadual yang dijangkakan; (b) kebolehan pihak-pihak untuk memenuhi jangkaan berhubung masa, penyelesaian dan perakaunan serta rawatan cukai untuk urus niaga berkenaan; (c) kemungkinan bahawa mana-mana faedah yang dijangkakan daripada urus niaga yang dicadangkan tidak akan direalisasikan atau tidak akan direalisasikan dalam tempoh masa yang dijangkakan; (d) risiko bahawa penyepaduan operasi Avon dengan operasi Natura akan ditangguhkan atau akan menjadi lebih mahal atau lebih sukar daripada yang dijangkakan; (e) kegagalan urus niaga yang dicadangkan untuk membuat penutupan atas apa-apa alasan lain; (f) kesan daripada pengumuman urus niaga tersebut terhadap hubungan pelanggan dan perunding seta keputusan operasi (termasuk, tanpa had, kesukaran untuk mengekalkan hubungan dengan kakitangan atau pelanggan); (g) pencairan yang disebabkan oleh penerbitan saham tambahan Natura daripada stok biasanya berhubung dengan urus niaga berkenaan; (h) kemungkinan bahawa urus niaga tersebut mungkin lebih mahal untuk diselesaikan daripada yang dijangkakan, termasuk hasil daripada faktor atau peristiwa yang tidak dijangkakan; (i) pengubahan masa pengurusan berhubung isu-isu berkaitan urus niaga; (j) kemungkinan bahawa perakaunan dan rawatan cukai yang dihasratkan untuk urus niaga yang dicadangkan tidak dicapai; (k) risiko-risiko yang dinyatakan dalam Bahagian 4 pada Borang Rujukan Natura bagi tahun 2018, versi 15, yang difailkan dengan Suruhanjaya Sekuriti Brazil pada 24 April 2019; dan (l) risiko-risiko yang dinyatakan dalam Item 1A daripada Laporan Tahunan yang difailkan baru-baru ini oleh Avon pada Borang 10-K dan laporan-laporan seterusnya pada Borang 10-Q dan 8-K. 

 

Are you a Corporate Representative of Natura &Co, an investor, or a member of the Business Press?



Syiling Perak Royal Canadian Mint Sambut Ulang Tahun ke-50 Give Peace A Chance Plastic Ono Band

By | MY, PR

MONTREAL, 24 Mei 2019 /PRNewswire/ — Pada tahun 1969, Plastic Ono Band (John Lennon dan Yoko Ono) merakamkan lagu Give Peace A Chance, sebuah lagu kebangsaan antiperang untuk generasi-generasi pencinta damai dan peminat-peminat muzik di seluruh dunia. Lagu tersebut dirakamkan secara langsung dari suit Queen Elizabeth Hotel Lennon dan Ono di pusat bandar Montreal, tempat John dan Yoko mengadakan bantahan "Bed-in for Peace" mereka yang terkenal. Lima puluh tahun kemudian, Mint merakamkan detik istimewa dalam sejarah Kanada dan muzik itu menerusi syiling perak tulen bagi meraikan bakat seni dan aktivisme sosial Lennon dan Ono, dalam satu perjanjian yang diaturkan oleh Epic Rights, ejen pelesenan global untuk John Lennon.




"Untuk generasi-generasi Kanada, muzik dan lirik John Lennon dan Yoko Ono telah menjadi sumber keseronokan dan juga inspirasi," kata Marie Lemay, Presiden dan Ketua Pegawai Eksekutif Royal Canadian Mint. "Kami berasa gembira kerana dapat menghasilkan syiling bagi meraikan hubungan istimewa Kanada bersama John dan Yoko serta pesanan keamanan mereka yang abadi."

"Sempena ulang tahun ke-50 Bed-in for Peace, kami berbesar hati kerana Royal Canadian Mint memberi penghormatan untuk meraikan detik berkenaan di hotel kami dan sejarah bandar raya kami dengan mengeluarkan syiling kenang-kenangan," ujar David Connor, Naib Presiden Serantau dan Pengurus Besar Fairmont The Queen Elizabeth. "Kami berharap agar ia akan membantu mempromosikan kesedaran yang lebih tinggi tentang pesanan keamanan oleh John dan Yoko yang masih mempunyai perkaitan dan kepentingan yang kuat pada hari ini."

Reka bentuk belakang syiling perak 99.99% tulen ini menampilkan penerapan gambar hitam dan putih yang terkenal John and Yoko oleh Ivor Sharp di "Bed-In for Peace" mereka yang diadakan di Montreal pada lewat musim bunga tahun 1969. Berpakaian pijama dan kedua-duanya memegang sekuntum bunga ros, mereka duduk di atas katil, dengan poster keamanan buatan tangan digantung di belakang mereka. Bahagian depan menampilkan potret timbul Ratu Elizabeth II oleh Susanna Blunt.

Terhad kepada tempaan 9,999 keping di seluruh dunia, syiling ini dijual dengan harga $99.99 CAD. Untuk maklumat latar belakang penuh tentang syiling ini boleh didapati di tab "Shop" www.mint.ca

Imej syiling disediakan di: https://www.dropbox.com/sh/qe24k8kmridut9l/AAA6y1sSwhLSvM849E2IXhHla?dl=0

Produk ini boleh dipesan terus daripada Mint di talian 1-800-267-1871 di Kanada, 1-800-268-6468 di AS, atau di laman sesawang Mint. Syiling ini juga boleh didapati di butik-butik Royal Canadian Mint di Ottawa dan Winnipeg, serta menerusi rangkaian peniaga dan pengedar global kami, termasuk outlet Canada Post yang mengambil bahagian.

Latar Belakang Royal Canadian Mint
Royal Canadian Mint ialah syarikat milik Kedaulatan Kanada yang bertanggungjawab terhadap penempaan dan pengedaran duit syiling edaran Kanada. Mint diiktiraf sebagai salah satu kilang wang yang terbesar dan paling versatil di dunia, menawarkan pelbagai pilihan produk duit syiling khusus dan berkualiti tinggi serta perkhidmatan berkaitan pada skala antarabangsa. Untuk maklumat lanjut mengenai Mint, produk dan juga perkhidmatannya, layari www.mint.ca.

Latar Belakang Epic Rights
Epic Rights ialah sebuah syarikat penjenamaan jualan, pembarangan dan perkhidmatan konsert artis dalam industri muzik yang terkemuka dan mewakili ramai artis terkenal. Epic Rights menyediakan skop perkhidmatan yang luas termasuk penjenamaan jualan dan pelesenan, laman sesawang artis rasmi dan pengurusan media sosial, kedai dalam talian konsert artis rasmi, tiket VIP, komuniti peminat rasmi dan perundingan pendaftaran tanda dagangan. Ibu pejabat Epic Rights terletak di Los Angeles, California. Untuk maklumat lanjut, kunjungi: www.epicrights.com

Untuk maklumat lanjut: Alex Reeves, Pengurus Kanan, Hal Ehwal Awam, Tel: (613) 884-6370, [email protected]

Foto – https://mma.prnewswire.com/media/891510/Royal_Canadian_Mint_Royal_Canadian_Mint_Silver_Coin_Celebrates_5.jpg

Related Links :

http://www.mint.ca

Are you a Corporate Representative of Royal Canadian Mint, an investor, or a member of the Business Press?



Gratomic Launches its First Graphene from Gratomic Graphite Derived Product

By | EN, PR

TSX-V: GRAT

TORONTO, May 25, 2019 /PRNewswire/ — Gratomic Inc. ("GRAT" or the "Company") (TSX-V: GRAT) (FRANKFURT:CB81, WKN:A143MR) is pleased to announce its first Graphene from Gratomic Graphite derived product.




Gratomic graphenes derived from Gratomic graphite mined from its Aukum Mine located in Namibia are being used to manufacture Graphene enabled conductive inks and pastes. The inks and pastes (to the best of the Company’s knowledge) are amongst the most conductive carbon inks and pastes currently available within the global market place.

The Gratink product is formulated specifically to meet the needs of the printed flexible electronics and EMI shielding markets. Electromagnetic interference (EMI), sometimes referred to as radio-frequency interference (RFI) is a disturbance generated by an external source that affects an electrical circuit by electromagnetic induction, electrostatic coupling, or conduction.

The Gratink and paste applications based on surface modified nano graphene "enablers" offer a product for market penetration into the information technology sector that is now an important aspect of our everyday life.  

The Gratomic Gratink product delivers a functional print and coat component solution.

Due to a multiple range of potential applications including antennas, RFID tags, transistors, sensors, and wearable electronics, the development of printed conductive inks and coatings for electronic applications is growing rapidly. Currently available conductive inks exploit metal nanoparticles to realize electrical conductivity.

Traditionally, metallic nanoparticles are normally derived from silver, copper and platinum based enablers which can be expensive and easily oxidized.

The Gratink product is designed to fill a gap in both the flexible printed electronics and EMI market space where metallic nanoparticle solutions are unnecessary.

Gratink is initially available to meet customer printing and coating preference specifications for R&D purposes with orders available in one-kilo packages.

Following satisfactory customer preproduction qualification, the products can then be varied so they are suitable for printing and coating in bulk quantities formulated to specification and made available as required in 10’s to 100’s of kilos or tonnes.

Please note – Inks and pastes are prepared for all currently available methods of printing and coating with the exception of ink jet printing.

Sheldon Inwentash Co-CEO of Gratomic commented. "Gratomic is delighted to offer their first product of a planned product range based on the Company’s graphene derived from graphite mined from its Aukum Mine."

Gratink is a collaborative development product formulated in tandem with Perpetuus Carbon Technology Wales UK and Gratomic Inc.

For more information, please visit https://gratomic.ca/sales

Gratomic continues to move its business towards production and as part of its business plan, expects to obtain a National Instrument 43-101 Standards of Disclosure for Mineral Projects technical report to help it ascertain the economics of Aukam.

Presently the Company uses its existing pilot processing facility to produce certain amounts of graphite concentrate from accumulated surface graphite.

Qualified Person

Steve Gray, P.Geo. has reviewed, prepared and approved the scientific and technical information in this press release and is Gratomic Inc’s "Qualified Person" as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects.

Risk Factors

The Company advises that it has not based its production decision on a feasibility study of mineral reserves, demonstrating economic and technical viability, and, as a result, there may be an increased uncertainty of achieving any particular level of recovery of minerals or the cost of such recovery, including increased risks associated with developing a commercially mineable deposit.

Historically, such projects have a much higher risk of economic and technical failure. There is no guarantee that production will begin as anticipated or at all or that anticipated production costs will be achieved.

Failure to commence production would have a material adverse impact on the Company’s ability to generate revenue and cash flow to fund operations. Failure to achieve the anticipated production costs would have a material adverse impact on the Company’s cash flow and future profitability.

About Gratomic Inc.

Gratomic is an advanced materials company focused on mine to market commercialization of graphite products most notably high value graphene based components for a range of mass market products. We are collaborating with a leading European manufacturer of graphenes to use Aukam graphite to manufacture graphene products for commercialization on an industrial scale. The company is listed on the TSX Venture Exchange under the symbol GRAT. 

"Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release."

FORWARD LOOKING STATEMENTS: This news release contains forward-looking statements, which relate to future events or future performance and reflect management’s current expectations and assumptions.  Such forward-looking statements reflect management’s current beliefs and are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward-looking statements are neither promises nor guarantees and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These forward-looking statements are made as of the date hereof and, except as required under applicable securities legislation, the Company does not assume any obligation to update or revise them to reflect new events or circumstances. All of the forward-looking statements made in this press release are qualified by these cautionary statements and by those made in our filings with SEDAR in Canada (available at www.sedar.com).

visit the website at www.gratomic.ca or contact: Arno Brand, Co-CEO, +1 416-561-4095, E-mail inquiries: [email protected] 

Photo – https://mma.prnewswire.com/media/892192/Gratomic_Gratomic_Launches_its_First_Graphene_from_Gratomic_Grap.jpg 

Related Links :

Home

Are you a Corporate Representative of Gratomic, an investor, or a member of the Business Press?



加拿大皇家造币厂银币纪念塑胶小野乐队《给和平一个机会》50周年

By | PR, SC

蒙特利尔2019年5月24日 /美通社/ — 1969年,塑胶小野乐队(Plastic Ono Band)(约翰-列侬和小野洋子)录制了《给和平一个机会》(Give Peace A Chance),这是一首为世界各地的几代和平主义者和音乐爱好者所唱的反战歌曲。这首歌是列侬和小野洋子在蒙特利尔市中心伊丽莎白女王酒店(Queen Elizabeth Hotel)套房现场录制的,当时列侬和小野洋子正在那里举行他们著名的“床上和平”抗议行动。五十年后,在一项由约翰-列侬的全球授权代理Epic Rights促成的交易中,加拿大皇家造币用一枚纯银硬币来纪念列侬和小野洋子的艺术才华和社会行动主义,捕捉加拿大和音乐史上那个特殊的时刻。

The Royal Canadian Mint's silver collector coin celebrating 50 years since Give Peace A Chance was recorded at Montreal's Queen Elizabeth Hotel


The Royal Canadian Mint’s silver collector coin celebrating 50 years since Give Peace A Chance was recorded at Montreal’s Queen Elizabeth Hotel

加拿大皇家造币厂总裁兼首席执行官Marie Lemay表示:“对于几代加拿大人来说,约翰-列侬和小野洋子的音乐和歌词一直是他们快乐和灵感的源泉。我们很高兴制作了一枚硬币来纪念加拿大与列侬和洋子的特殊联系,以及他们传达的经久不衰的和平信息。”

Fairmont The Queen Elizabeth(费尔蒙伊丽莎白女王酒店)区域副总裁兼总经理David Connor表示:“为了纪念‘床上和平’行动50周年,加拿大皇家造币厂发行了一枚纪念币,来纪念我们酒店和这座城市历史的一个标志性时刻,对此我们感到很荣幸。我们希望这将有助于提高人们对列侬和洋子传达的和平信息的认识,这一信息今天仍然具有强烈的共鸣和重要性。”

这枚99.99%纯银硬币的反面图案是艾弗-夏普(Ivor Sharp)著名的黑白照片,照片上的列侬和洋子在1969年春末在蒙特利尔举行“床上和平”行动。他们穿着睡衣,手捧玫瑰,坐在床上,身后挂着手工制作的和平海报。硬币正面是苏珊娜-布朗特(Susanna Blunt)创作的伊丽莎白女王二世(Queen Elizabeth II)肖像。

全世界范围内限量铸造9,999枚,零售价为99.99加元。关于这枚硬币的全部背景信息可在www.mint.ca的“商店”标签中找到。

硬币图片可参见https://www.dropbox.com/sh/qe24k8kmridut9l/AAA6y1sSwhLSvM849E2IXhHla?dl=0

该产品可以从加拿大皇家造币厂直接预订,电话:1-800-267-1871(加拿大),1-800-268-6468(美国),也可以在该造币厂的网站上在线订购。这些硬币还将在加拿大皇家造币厂的渥太华和温尼伯精品店发售,并通过我们的全球经销商和分销商网络(包括参与其中的加拿大邮政(Canada Post)门店)出售。

相关链接 :

http://www.mint.ca

Are you a Corporate Representative of Royal Canadian Mint, an investor, or a member of the Business Press?



Five Directors of Golden Meditech Voluntarily Resigned Due to Personal Reasons

By | EN, PR

New Members on Board, the Company’s Major Shareholder Maintains Full Confidence in Future Business Development

HONG KONG, May 24, 2019 /PRNewswire/ — Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise in China, announced that, Mr Kam Yuen ("Mr Kam") and Mr Kong Kam Yu ("Mr Kong"), executive directors of the Company, Ms Zheng Ting ("Ms Zheng"), non-executive director, Professor Gu Qiao and Professor Cao Gang, independent non-executive directors, voluntarily resigned due to personal reasons.

Mr Kam has resigned as chairman, chief executive, executive director and one of the authorised representatives of the Company; Mr Kong has resigned as executive director, company secretary and qualified accountant of the Company; Ms Zheng has resigned as one of the authorised representatives of the Company, all with effect from 24 May 2019.

Mr Kam, the founder of the Company, initially established the Company with a single medical devices business and has transformed it into an integrated healthcare enterprise with businesses covering hospital, cells and tissues storage, genetic testing services and medical insurance administration. The board of directors of the Company (the "Board") is regretful to learn of his voluntary resignation and would like to take this opportunity to express sincere gratitude to him for his 18-year outstanding contribution since the Company was listed on the Stock Exchange of Hong Kong Limited in 2001. Mr Kong, Ms Zheng, Professor Gu Qiao and Professor Cao Gang had performed their duties with diligence for more than a decade. The Board also deeply regrets his/her voluntary resignation and would like to thank them for their valuable contributions.

The Board is pleased to announce that all with effect from 24 May 2019, Mr Feng Wen, the Company’s current executive director, has been appointed as chairman of the Company; Mr Leong Kim Chuan, the Company’s current deputy chief financial officer, has been appointed as chief executive and executive director of the Company; Mr Poon Tsz Hang has been appointed as independent non-executive director of the Company. Additionally, the Board will recruit suitable senior professionals who have extensive resources and experiences in the healthcare industry to join the Company’s senior management team and points out that the Company’s business operations will proceed as usual. Mr Kam, the Company’s major shareholder, has also expressed his full confidence in the future business development of the Group.

About Golden Meditech Holdings Limited (SEHK stock code: 00801)

Golden Meditech (www.goldenmeditech.com) is a leading integrated-healthcare enterprise in China. It is a first-mover in China, having established its dominant positions in several markets including the medical devices market and the hospital market in the healthcare industry, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities. Going forward, Golden Meditech will continue to pursue a leading position in China’s healthcare industry both through organic growth and strategic expansion.

Related Links :

http://www.goldenmeditech.com

Are you a Corporate Representative of Golden Meditech Holdings Limited, an investor, or a member of the Business Press?



VT Holdings Co., Ltd. (7593, First Section, Tokyo Stock Exchange) Overview of Operating Performance for the Fiscal Year Ended March 31, 2019

By | EN, PR

TOKYO, May 24, 2019 /PRNewswire/ — VT Holdings Co., Ltd. (TOKYO: 7593) is pleased to announce its results for the Fiscal Year Ended March 31, 2019.

Summary of Results

In the core automotive business, domestic results were relatively strong during the fiscal year ended March 31, 2019. These robust results were due in part to the impact of new Honda models. Also, sales of Nissan vehicles equipped with e-POWER were favorable, as were sales of electric vehicles. Overseas, the Company acquired three subsidiaries in Spain and South Africa as operating companies from the previous fiscal year through the second quarter of the period under review and was able to add their sales to consolidated business results. The Group’s total of new and second-hand cars sold in the period under review was 101,646, up 6,487 (6.8%) year on year. Meanwhile, performance remained favorable in the housing-related business as the Company received orders for condominium construction projects. However, performance by three consolidated subsidiaries fell below initial forecasts, causing the financial condition to deteriorate. Accordingly, the Company posted JPY872 million in impairment losses as an extraordinary loss.

During the fiscal year ended March 31, 2019, VT Holdings recorded consolidated net sales of JPY218,634 million (up 8.2% YoY), operating income of JPY6,130 million (down 9.6%), ordinary income of JPY6,385 million (down 29.0%) and profit attributable to owners of parent of JPY2,674 million (down 29.0%).

In the automotive business, sales were JPY209,087 million (up 8.3% YoY), and operating income was JPY5,568 million (down 12.9%).

In the new car segment of the automotive business, the number of new cars sold groupwide domestically and internationally was 45,241 (up 12.9% YoY). Profitability declined, however, as the Company prioritized efforts to bolster unit sales by increasing the number of customers under management, bringing down unit profits on new-vehicle sales.

In the used car segment, the number of second-hand cars sold for the entire Group was 56,405 (up 2.4% YoY), with used car sales and profits rising year on year.

In the service segment of the automotive business, both existing and newly consolidated subsidiaries concentrated on boosting orders for routine and officially mandated checks, repairs and commission revenue. Consequently, although sales were down slightly, income increased. In the rent-a-car segment, sales and income both rose year on year thanks to solid operations at new and existing agencies alike.

Sales in the housing-related business were JPY9,355 million (up 4.7%) YoY), and operating income was JPY918 million (up 24.9%).

In the housing-related business, demand was firm and selling prices soared. Due to a thorough focus on marketing, the Company sold nine newly build condominium buildings containing 288 units, bringing its total number of concluded condominium agreements, including those on condominiums completed in inventory, to 243 (163 in the previous fiscal year), and the number of condominiums transferred to 199 (178 in the previous fiscal year). The condominium construction business was generally favorable, and the Company worked to expand orders for commercial facilities.

In the fiscal year ending March 31, 2020, the Japanese government is planning to raise the consumption tax rate. Domestic automobile sales are likely to see a temporary demand surge ahead of the tax hike, falling off and causing the market to shrink once the higher taxes are in place. These fluctuations make the future difficult to forecast. Nevertheless, the Company will continue to concentrate on expanding new car sales, improving customer satisfaction, improving core sales and profits in the used-car and service segments, and striving to expand operations through M&A. For the fiscal year ending March 31, 2020, the company forecasts consolidated net sales of JPY225.0 billion, operating profit of JPY8.3 billion, profit before tax of JPY8.0 billion and profit attributable to owners of parent of JPY4.7 billion. Consolidated performance forecasts for the fiscal year ending March 31, 2020, are calculated in accordance with IFRS rather than conventional Japanese accounting standards.

For the fiscal year ended March 31, 2019, the Company targeted a consolidated dividend payout ratio of 40%. This figure actually amounted to 87.8%, based on annual dividends per share of JPY20 (including a year-end dividend of JPY10 per share). The Company also plans to award interim and year-end dividends of JPY10 per share for the fiscal year ending March 31, 2020.

VT Holdings Co., Ltd. (7593, First Section, TSE) "Summary of Consolidated Financial Results for the Year Ended March 31, 2019" is available here: http://www.vtholdings.co.jp/eng/index.html

Release Disclaimer

This release is for the purpose of providing information to serve as a reference for investment decisions and not for the purpose of soliciting investment. Please make your own judgment on final decisions such as investment policy, timing and selection. Please be advised that we do not assume any responsibility for damages caused by this service.

Release Inquiries

Borderless IR Co., Ltd. 
Sixth Floor, Toyo Building 1-2-10 Nihonbashi, Chuo-ku, Tokyo 103-0027 JAPAN TEL: +81-3-4588-6706 [email protected]

Borderless IR specializes in the overseas distribution of IR content, including the dissemination of newsletters and annual reports providing the latest information and main strengths of Japanese companies directly to overseas investors through leading global media, corporate information database services and mailing lists. Borderless is also engaged in supporting other global IR efforts.

© Borderless IR Co., Ltd. All rights reserved
Unauthorized reproduction of this release or any of its content is strictly prohibited.

Cision View original content:http://www.prnewswire.com/news-releases/vt-holdings-co-ltd-7593-first-section-tokyo-stock-exchange-overview-of-operating-performance-for-the-fiscal-year-ended-march-31-2019-300856445.html

Are you a Corporate Representative of VT Holdings Co., Ltd., an investor, or a member of the Business Press?



Daiki Axis Co., Ltd. (4245, First Section, Tokyo Stock Exchange) Overview of Operating Performance for the First Three Months Ended March 31, 2019

By | EN, PR

TOKYO, May 24, 2019 /PRNewswire/ — Daiki Axis (TOKYO: 4245) is pleased to announce its results for the three months ended March 31, 2019.

Summary of Results

The Company has formulated a new medium-term management plan, "Make FOUNDATION Plan (Promote ESG)," for the fiscal years ending December 31, 2019 to 2021. The company started off the plan by transitioning to a company with an audit and supervisory committee and introducing an executive officer system. The Company’s main business strategy is to focus on ensuring future revenue and profits through several initiatives. First, in the environmental equipment segment, the Company is bolstering sales overseas and strengthening the management of its recurring-revenue energy service company (ESCO) businesses in the areas of maintenance and water utilities. Second, Daiki Axis is transitioning toward growth businesses in the household equipment-related business segment. Third, in the renewable energy segment the company is working to realize a recycling society and striving to shore up stable revenue and profits.

During the first three months of the fiscal year ending December 31, 2019, the Company generated net sales of JPY9,750 million (up 0.3% YoY), operating income of JPY470 million (up 23.1% YoY), ordinary income of JPY513 million (up 21.4% YoY) and profit attributable to owners of parent of JPY302 million (up 25.3% YoY).

In the environmental equipment segment, sales of wastewater treatment systems were up year on year. Performance in Japan was affected by the posting of sales based on the percentage-of-completion-system for recognizing revenues on large-scale projects and the completion of five projects involving the sale of equipment in the water utilities business (excluding ESCO). Overseas sales rose as the Company made progress in cultivating distributors. Sales also grew year on year in the recurring-revenue energy service company (ESCO) businesses in the areas of maintenance and water utilities. Sales in the environmental equipment segment accordingly amounted to JPY5,668 million (up 17.3% YoY), and segment income (operating income) was JPY556 million (up 33.7% YoY).

Sales and income were both down in the household equipment-related business segment. In construction-related sales, the Company saw few medium-sized or large projects, and sales of retail products through DIY stores were down due to lower sales to existing stores. Also, in the construction of residential machinery the company did not benefit from large scale store construction as it had in the preceding fiscal year. Consequently, segment sales in the household equipment-related business segment came to JPY3,523million (down 19.3% YoY), and segment income (operating income) sales were JPY89 million (down 45.5% YoY).

In the renewable energy segment, sales of electricity from solar power generation rose significantly as the Company steadily commenced electricity sales. In addition, sales of biodiesel fuel were up year on year. The Company posted no sales results for the compact wind generation business. Consequently, segment sales came to JPY114 million (up 184.5% YoY), and segment income (operating income) was JPY22 million (a segment loss [operating loss] of JPY56 million in the same period of the previous year.)

In other segments, construction sales in the engineering business were down year on year in the first quarter. Sales were essentially flat year on year in the household water drinking business. As a result, segment sales were JPY443 million (down 8.6% YoY), and segment income (operating income) was JPY30 million (down 50.9% YoY).

Daiki Axis Co., Ltd. (4245, First Section, TSE) "Summary of Consolidated Financial Results for the Three Months Ended March 31, 2019" is available here:
Summary of Consolidated Financial Results for the Three Months Ended March 31, 2019

Release Disclaimer

This release is for the purpose of providing information to serve as a reference for investment decisions and not for the purpose of soliciting investment. Please you’re your own judgment on final decisions such as investment policy, timing and selection. Please be advised that we do not assume any responsibility for damages caused by this service.

Release Inquiries
Borderless IR Co., Ltd.
Sixth Floor, Toyo Building 1-2-10 Nihonbashi, Chuo-ku, Tokyo 103-0027 JAPAN
TEL: +81-3-4588-6706
[email protected]b-ir.co.jp

Borderless IR specializes in the global distribution of IR content, including the dissemination of newsletters and annual reports providing the latest information and main strengths of Japanese companies directly to overseas investors through leading global media, corporate information database services and mailing lists. Borderless is also engaged in supporting other global IR efforts.

©Borderless IR Co., Ltd. All rights reserved
The content of this release may not be duplicated or reproduced.

Cision View original content:http://www.prnewswire.com/news-releases/daiki-axis-co-ltd-4245-first-section-tokyo-stock-exchange-overview-of-operating-performance-for-the-first-three-months-ended-march-31-2019-300856440.html

Are you a Corporate Representative of Daiki Axis Co., Ltd., an investor, or a member of the Business Press?



Sasol Limited: Kemas kini Projek Lake Charles Chemical

By | MY, PR

JOHANNESBURG, 24 Mei 2019 /PRNewswire/ — Sasol kini telah mengemaskini panduannya untuk LCCP berikutan proses semakan untuk menilai kos dan jadual projek.

  • Jadual LCCP masih berada di landasan dengan Unit Etilena Glikol/Etilena Oksida dijangka mencapai operasi yang bermanfaat dalam masa beberapa hari. Satu-satunya perubahan kepada jadual ialah Unit Guerbet yang kini akan beroperasi pada bulan Februari 2020. Setakat penghujung Mac 2019 penyiapan projek adalah pada 96% dengan penyelesaian pembinaan pada 89%.
  • Sasol tetap yakin bahawa prospek EBITDA jangka panjang untuk LCCP kekal teguh.
  • Jumlah kos modal ramalan untuk projek meningkat kepada $12.6 – 12.9 bilion, termasuk $300 juta kontingensi. Pemacu perubahan kos modal difahami dan satu siri tindakan pelegaan sedang diambil untuk memastikan penghantaran disiapkan dalam parameter yang telah dipinda.
  • Lembaran imbangan Sasol cukup mantap dan tindakan pengurusan difokuskan untuk menghapuskan hutang pada kunci kira-kira, mempermudah portfolio aset dan melaksanakan strategi berasaskan nilai kami.

LATAR BELAKANG

Dalam kenyataan perdagangan Syarikat, yang dikeluarkan oleh Perkhidmatan Berita Bursa Saham pada 8 Februari 2019, panduan yang dikemas kini disediakan untuk jadual LCCP dan kos modal, yang dianggarkan dalam lingkungan $ 11.6$ 11.8 bilion. Berikutan pengumuman ini beberapa perubahan telah dibuat kepada pengurusan LCCP, dengan akauntabiliti projek serta merta ditugaskan kepada Naib Presiden Eksekutif Bahan Kimia, Fleetwood Grobler dan pengukuhan organisasi kawalan projek kami.

Pasukan ini bimbang terhadap ketepatan ramalan kos projek dan, kesannya, pengumuman Metrik Prestasi Perniagaan suku ketiga kami pada April 2019 menunjukkan bahawa kos LCCP berada di bahagian atas julat. Pengurusan juga memulakan semakan penuh kos dan jadual sehingga selesai projek dengan input daripada penasihat teknikal dan kewangan bebas.

Kajian ini mengenalpasti kebimbangan tambahan yang penting berkaitan dengan proses ramalan LCCP dan peningkatan yang ketara dalam jumlah kos yang diunjurkan. Semakan semula itu juga mengesahkan bahawa perbelanjaan projek sebenar pada 31 Disember 2018 berjumlah $ 10.9 bilion adalah tepat dan lengkap. Kelemahan dalam kawalan bersepadu projek telah dikenalpasti dan sedang dipulihkan.

Lembaga Pengarah juga telah menugaskan semakan semula dijalankan oleh pakar luar bebas. Semakan semula ini akan merangkumi keadaan yang mungkin menangguhkan pengenalpastian dan pelaporan segera perkara-perkara yang disebutkan di atas. Setelah semakan semula selesai, Lembaga akan mengambil tindakan yang sewajarnya untuk menangani dapatan-dapatan ini.

KEMASKINI PADA PARAMETER PROJEK UTAMA

Unit derivatif pertama, Linear Low Density Polyethylene (LLDPE), mencapai operasi yang bermanfaat pada 13 Februari 2019 dan kilang itu terus meningkat selaras dengan jangkaan. Kami telah mencapai operasi yang bermanfaat dalam unit Ethylene Glycol (EG), dengan operasi yang berfaedah dari unit Ethylene Oxide (EO) yang dijangka pada masa akan datang. Ethane Cracker masih dijangka akan mencapai operasi bermanfaat pada bulan Julai 2019. Jadual LCCP untuk operasi bermanfaat yang selebihnya adalah sebagaimana yang dinyatakan pada Februari 2019 selain daripada operasi bermanfaat kilang derivatif terakhir (unit Guerbet), yang dijangka sebulan kemudian pada bulan Februari 2020. Sehingga akhir Mac 2019, keseluruhan penyempurnaan projek adalah 96%, dengan penyelesaian pembinaan pada 89% dan perbelanjaan modal pada projek berjumlah $11.4 bilion.

Berikutan semakan semula yang dinyatakan di atas, anggaran kos untuk LCCP telah disemak semula kepada julat $12.6$12.9 bilion yang termasuk kontinjensi sebanyak $300 juta. Faktor utama yang memberi kesan kepada anggaran kos yang telah dipinda untuk melengkapkan LCCP adalah pelarasan untuk ramalan kos Februari 2019 kira-kira $530 juta dan peristiwa tambahan serta kerja yang memberi kesan kepada ramalan kos Februari 2019 – kira-kira $470 juta. Satu kontinjensi sebanyak $300 juta juga telah dimasukkan.

TINDAKAN SETAKAT INI

Peningkatan kos modal LCCP yang dijangkakan ini sangat mengecewakan. Pengurusan eksekutif telah melaksanakan beberapa perubahan sejak Februari 2019 untuk mengukuhkan lagi pengawasan, kepimpinan untuk projek dan kekerapan pelaporan. Tindakan termasuk pengasingan tugas antara kawalan projek dan fungsi kewangan dan melantik Naib Presiden Kanan untuk bertanggungjawab terhadap kawalan projek LCCP. Inisiatif untuk meningkatkan pembuatan keputusan, ketelusan dan dokumentasi dalam pasukan pengurusan projek juga sedang dilaksanakan. Kepimpinan projek baharu telah memainkan peranan penting dalam mengenalpasti dan mengatasi masalah ini.

Semakan semula dan siasatan yang dimulakan oleh pengurusan sehingga kini menunjukkan kelemahan kawalan yang mendasari adalah terhad kepada LCCP.

KESAN KEWANGAN

Peningkatan kos LCCP tidak mengubah strategi peruntukan modal Sasol. Rencananya untuk mengurangkan penyusunan lembaran imbangan ke arah 30% hutang diikuti dengan kenaikan nisbah pembayaran dividen kepada 40% dan masih kekal dalam perancangan untuk berlaku antara tahun kewangan 2020 hingga 2023. Sepanjang tempoh ini sumbangan yang diharapkan daripada LCCP telah dipengaruhi secara negatif oleh perubahan dalam prospek harga jangka pendek dan sederhana. Kos operasi untuk LCCP, walaupun dijangka naik sedikit semasa permulaan, sebaliknya masih selaras dengan panduan terdahulu. Akibatnya, pendapatan sebelum faedah, cukai, susutnilai dan pelunasan (EBITDA) untuk tahun kewangan 2022 sebanyak $1.3 bilion telah disemak semula kepada kira-kira $1 bilion. Tinjauan harga pasaran jangka panjang masih menyokong sumbangan kadar jangka panjang EBITDA daripada LCCP sebanyak $1.3 bilion. Tinjauan pasaran jangka pendek untuk etana dan harga produk tetap tidak menentu dan anggaran akan dikemas kini secara berkala.

Seperti yang disampaikan kepada pasaran sebelum ini, pihak pengurusan telah menyelesaikan secara lengkap program semakan aset terperinci. Proses ini membentuk bahagian utama strategi pengoptimalan portfolio, dan kini telah berkembang ke peringkat di mana pelupusan aset bukan teras yang lebih besar dapat dipercepat. Syarikat akan menyasarkan pelupusan aset yang mempunyai nilai aset bersih agregat melebihi $2 bilion. Nilai perlindungan akan diutamakan melalui proses ini, dan metrik kewangan yang dinyatakan di atas tidak bergantung kepada pelupusan aset. Oleh itu, pelupusan yang berkaitan akan terus menyokong pengurangan hutang kunci kira-kira, serta mempermudahkan portfolio pelaburan dan meningkatkan tumpuan dalam melaksanakan strategi berasaskan nilai kami.

Penafian – Kenyataan pandang ke hadapan

Sasol boleh, dalam dokumen ini, membuat kenyataan tertentu yang bukan fakta sejarah dan berkaitan dengan analisis dan maklumat lain yang berdasarkan pada ramalan keputusan masa depan dan anggaran jumlah yang belum dapat ditentukan. Kenyataan ini mungkin juga berkaitan dengan prospek, perkembangan dan strategi perniagaan masa depan. Contoh-contoh kenyataan pandang ke hadapan ini termasuk, tetapi tidak terhad kepada, anggaran kos dan jangkaan masa operasi bermanfaat LCCP, sasaran atau panduan mengenai nisbah hutang kami dan nisbah pembayaran dividen, nisbah hutang kepada EBITDA bersih, EBITDA dan kadar pulangan dalaman untuk LCCP, serta kenyataan mengenai kecairan masa depan, penarafan kredit dan strategi pelupusan aset bukan teras. Kata-kata seperti "percaya", "menjangkakan", "mengharapkan", "berhasrat", "mencari", "akan", "merancang", "boleh", "berusaha", "menyasarkan", "meramal" dan "mengunjurkan" dan ungkapan yang serupa bertujuan untuk mengenal pasti kenyataan pandang ke hadapan itu, tetapi bukan merupakan cara eksklusif untuk mengenal pasti kenyataan tersebut. Secara semula jadinya, kenyataan pandang ke hadapan melibatkan risiko dan ketidakpastian yang wujud, baik umum dan khusus, dan terdapat risiko telahan, ramalan, unjuran dan kenyataan pandang ke hadapan lain tidak akan tercapai. Jika satu atau lebih daripada risiko-risiko ini menjadi kenyataan, atau andaian yang mendasari terbukti tidak betul, keputusan sebenar kami mungkin berbeza secara material daripada jangkaan. Anda harus memahami bahawa beberapa faktor penting boleh menyebabkan keputusan sebenar berbeza secara material daripada rancangan, objektif, jangkaan, anggaran dan niat yang dinyatakan dalam kenyataan pandang ke hadapan itu. Faktor-faktor ini dibincangkan dengan lebih lanjut dalam laporan tahunan terbaharu kami pada Borang 20-F yang difailkan pada 28 Ogos 2018 dan dalam pemfailan lain dengan Suruhanjaya Sekuriti dan Bursa Amerika Syarikat. Senarai faktor yang dibincangkan di dalamnya tidak menyeluruh; apabila bergantung pada kenyataan pandang ke hadapan untuk membuat keputusan pelaburan, anda perlu mempertimbangkan dengan teliti kedua-dua faktor ini dan ketidakpastian dan peristiwa-peristiwa lain. Kenyataan pandang ke hadapan hanya terguna pakai pada tarikh ia dibuat, dan kami tidak mempunyai apa-apa kewajipan untuk mengemaskini atau menyemak mana-mana kenyataan, sama ada kesan daripada maklumat baharu, peristiwa masa hadapan atau sebaliknya.

Latar Belakang Sasol: 

Sasol ialah syarikat kimia dan tenaga bersepadu global. Melalui pekerja berbakat kami, kami mewujudkan nilai yang lebih baik untuk pelanggan, pemegang saham dan pemegang kepentingan yang lain dengan selamat dan mampan. Kami menyepadukan teknologi canggih dalam kemudahan operasi berskala dunia untuk menghasilkan dan mengkomersialkan komoditi dan kimia khusus, bahan api gas dan cecair, dan elektrik lebih rendah karbon.

Are you a Corporate Representative of Sasol Limited, an investor, or a member of the Business Press?



111 to Collaborate with MSH to Build Internet Pharmaceutical and Healthcare Service Closed-loop System

By | EN, PR

SHANGHAI, May 24, 2019 /PRNewswire/ — Following 111, Inc.’s (NASDAQ: YI) ("111" or the "Company") strategic partnership with Manulife-Sinochem last year, the Company has reached another milestone. On May 24, 111 and MSH, a world leader in the design and management of international healthcare solution, announced a strategic partnership aiming to combine resources to establish a comprehensive "diagnosis + medication + payment" Internet pharmaceutical and healthcare service closed-loop system by launching online diagnoses, prescription purchase and delivery, refills, health monitoring, patient management services, and enhance the pharmacy benefit management ("PBM") model.

Currently, the percentage of patients with chronic diseases in China continues to increase rapidly due to factors such as an intensive aging population and environmental pollution. Given the high number of chronically ill patients in China, the need for long term medications, high drug prices, and reliance on physician refills, the "Internet + insurance" model will aim to lessen the burden of chronically ill patients by providing them with a new solution to purchase and refill medications.

According to Dr. Gang Yu, Co-Founder and Executive Chairman of 111, given the diverse geographical nature and online payment restrictions in China’s healthcare system, commercial health insurance plans are becoming an important supplement. To solve the shortage of medical resources and disproportionate distribution, 111’s innovative "Internet + insurance" model will serve to reduce current healthcare pressures and to achieve a win-win among users, insurance providers and our national healthcare system.

Dr. Gang Yu, Co-Founder and Executive Chairman of 111, expressed that, given the diverse geographical nature and online payment restrictions of China’s healthcare system, commercial health insurance plans are becoming an important supplement. To resolve the shortage of medical resources and disproportionate distribution, our innovative "Internet + insurance" model will serve to ameliorate current healthcare pressures and to achieve win-win among users, insurance providers and our national healthcare system.

He further summarized, "For chronical patients, we can deliver the ‘fast refills + end-to-end delivery’ through our closed-loop system, providing a convenient solution to reduce drug expenses while improving patient adherence and overall health. Insurance providers will be able to leverage our big data and advanced technologies to improve cost control, medication compliance efficiency and margin. Our system will also support customized products development, product strategies and precision marketing."

As a leader in China’s Internet pharmaceutical and healthcare industry, 111 has built an integrated online and offline healthcare new retail platform which includes 111’s B2C pharmaceutical platform "1 Drugstore", online medical services internet hospital "1 Clinic", and online wholesale pharmacy "1 Drug Mall". The fully integrated online to offline platform effectively combines patient medical services with drugs, B and C-side clients, and direct sales platform through our innovative T2B2C model. The company aims to build an integrated online and offline healthcare ecosystem to empower doctors, pharmacies, hospitals and clinics, pharmaceutical companies and insurance companies.

Celine Zhang, the founder and CEO of MSH CHINA, said, "111 has developed deep roots in the field of health and Internet medicine for many years, established unique competitive barriers through technological advantages, and improved the accessibility of quality medical services through Internet technology. The cooperation between MSH and 111 will place users at the center, explore the health, medical and insurance needs of middle and high-end consumers based on big data, jointly develop insurance products, and open up an integrated service channel around the ecological closed loop of medical and health services."

About MSH CHINA

Founded in 1974, MSH INTERNATIONAL is a world leader in the design and management of international healthcare solutions. Its four regional headquarters located in Paris, Toronto, Dubai and Shanghai, MSH INTERNATIONAL provides 24/7, round-the-clock assistance in 40 languages for its corporate clients and insured members across 200 countries. As the Asia pacific headquarter of MSH INTERNATIONAL, MSH CHINA has a professional service team consists of 550 staff, over 70 staff of whom have professional medical background. The average tenure of the core team is nearly 8 years. MSH is capable of providing clients with most thoughtful services in Chinese, English, French, Japanese, Korean and Cambodian.

For more information on MSH, please visit http://www.mshasia.com/ 

About 111, Inc.

111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading integrated online and offline healthcare platform in China. The Company provides hundreds of millions of consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy and indirectly through its offline pharmacy network. 111 also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation and electronic prescription services. In addition to providing direct services to consumers through its online retail pharmacy, 111 also enables offline pharmacies to better serve their customers. The Company’s online wholesale pharmacy, 1 Drug Mall, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. The Company’s new retail platform, by integrating the front and back ends of the pharmaceutical supply chain, has formed a smart supply chain, which transforms the flow of pharmaceutical products to pharmacies and modernizes how they serve their customers.

For more information on 111, please visit http://ir.111.com.cn 

For more information, please contact:
111, Inc.
IR Director
Ms. Monica Mu
[email protected] 

Christensen
In China
Mr. Christian Arnell
Phone: +86-10-5900-1548
E-mail: [email protected]

In US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
Email: [email protected] 

Cision View original content:http://www.prnewswire.com/news-releases/111-to-collaborate-with-msh-to-build-internet-pharmaceutical-and-healthcare-service-closed-loop-system-300856555.html

Related Links :

http://ir.111.com.cn

Are you a Corporate Representative of 111, Inc., an investor, or a member of the Business Press?